삼성전자, 갤럭시 J4+ 출시
 |
몰도바, 투자 통한 시민권 취득 프로그램 신청 접수 개시
가장 최근에 나오고 유럽에서 가장 큰 관심을 끄는 투자이민 기회인 몰도바의 투자 통한 시민권 취득 프로그램(Moldova Citizenship-by-Investment[MCBI] program)이 두바이에서 개최되는 제12회 글로벌 주거 및 시민권 컨퍼런스(12th Global Residence and Citizenship Conference)에서 공식 발표됐다.
헨리 앤 파트너스(Henley & Partners)가 주최하는 이 연례 행사는 40여 국가에서 400명 이상의 대표들이 참가하...
The New Moldova Citizenship-by-Investment Program is Open for Applications
The Moldova Citizenship-by-Investment (MCBI) program — the latest and most exciting new investment migration opportunity in Europe — has been officially launched at the 12th Global Residence and Citizenship Conference in Dubai. Hosted by Henley & Partners, this annual event attracts over 400 delegates from more than 40 countries and is the largest and most important conference focused on investment migration.
Earlier this year, Henley & Partners — in partnership with its consortium part...
몰도바, 투자 통한 시민권 취득 프로그램 신청 접수 개시
가장 최근에 나오고 유럽에서 가장 큰 관심을 끄는 투자이민 기회인 몰도바의 투자 통한 시민권 취득 프로그램(Moldova Citizenship-by-Investment[MCBI] program)이 두바이에서 개최되는 제12회 글로벌 주거 및 시민권 컨퍼런스(12th Global Residence and Citizenship Conference)에서 공식 발표됐다.
헨리 앤 파트너스(Henley & Partners)가 주최하는 이 연례 행사는 40여 국가에서 400명 이상의 대표들이 참가하...
The New Moldova Citizenship-by-Investment Program is Open for Applications
The Moldova Citizenship-by-Investment (MCBI) program — the latest and most exciting new investment migration opportunity in Europe — has been officially launched at the 12th Global Residence and Citizenship Conference in Dubai. Hosted by Henley & Partners, this annual event attracts over 400 delegates from more than 40 countries and is the largest and most important conference focused on investment migration.
Earlier this year, Henley & Partners — in partnership with its consortium part...
Rimini Street Receives 100 Percent Renewable Energy Certification for Data Center Operations
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, and the leading third-party support provider for Oracle and SAP software products, today announced it has achieved its sustainability goal of using 100 percent renewable energy at its data facility operating within Switch’s Data Centers (NYSE: SWCH). Because Switch is powered by 100 percent clean energy, Rimini Street operations at Switch’s Data Centers result in zero greenhouse gas emissions....
Rimini Street Receives 100 Percent Renewable Energy Certification for Data Center Operations
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, and the leading third-party support provider for Oracle and SAP software products, today announced it has achieved its sustainability goal of using 100 percent renewable energy at its data facility operating within Switch’s Data Centers (NYSE: SWCH). Because Switch is powered by 100 percent clean energy, Rimini Street operations at Switch’s Data Centers result in zero greenhouse gas emissions....
Initial results from EMPRISE real-world evidence study shows empagliflozin was associated with reduced risk for hospitalisation for heart failure compared with DPP-4 inhibitors in people with type 2 diabetes with and without cardiovascular disease
Initial effectiveness results from the real-world EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study showed empagliflozin was associated with a 44 percent relative risk reduction in hospitalisation for heart failure (HHF) compared with dipeptidyl peptidase-4 (DPP-4) inhibitors in routine clinical practice in the U.S. The EMPRISE analysis of data from approximately 35,000 people with type 2 diabetes between August 2014 and September 2016 will be presented at the American Heart Ass...
Initial results from EMPRISE real-world evidence study shows empagliflozin was associated with reduced risk for hospitalisation for heart failure compared with DPP-4 inhibitors in people with type 2 diabetes with and without cardiovascular disease
Initial effectiveness results from the real-world EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study showed empagliflozin was associated with a 44 percent relative risk reduction in hospitalisation for heart failure (HHF) compared with dipeptidyl peptidase-4 (DPP-4) inhibitors in routine clinical practice in the U.S. The EMPRISE analysis of data from approximately 35,000 people with type 2 diabetes between August 2014 and September 2016 will be presented at the American Heart Ass...
루닛, NH투자증권과 상장 주관사 계약 체결
 |